Using advanced imaging to understand how living cells respond to treatments
Vibrational Spectroscopic Imaging to Unveil Hidden Signatures in Living Systems
['FUNDING_OTHER'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-10875578
This study is looking at how tiny molecules in our cells react to different treatments, like medications, to help doctors create more personalized and effective treatments for diseases such as cancer and infections, especially for those tough-to-treat cases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10875578 on ClinicalTrials.gov |
What this research studies
This research investigates how biomolecules and molecular assemblies function in living systems, particularly focusing on how cells respond to various stimuli such as drug treatments. The team employs innovative imaging technologies to uncover hidden chemical signatures that can inform the diagnosis and treatment of diseases, including cancers and infectious diseases. By studying cellular responses at a molecular level, the research aims to develop precision medicine approaches that tailor treatments to individual patients. The project includes specific efforts to combat drug-resistant bacteria and enhance neural tissue responses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cancers, infectious diseases, or those affected by drug-resistant bacteria.
Not a fit: Patients with conditions unrelated to cellular metabolism or those not responding to drug treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for a range of diseases, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques to improve disease diagnosis and treatment, indicating that this approach has potential for success.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHENG, JI-XIN — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: CHENG, JI-XIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Communicable Diseases